Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Neoplasms and PIK3CB[original query] |
|---|
| Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. International journal of cancer 2006 May 118 (10): 2644-6. Phillips Wayne A, Russell Sarah E, Ciavarella Marianne L, Choong David Y H, Montgomery Karen G, Smith Katherine, Pearson Richard B, Thomas Robert J S, Campbell Ian |
| Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. Journal of cancer research and clinical oncology 2012 Mar 138 (3): 377-85. Wang Li-E, Ma Hongxia, Hale Katherine S, Yin Ming, Meyer Larissa A, Liu Hongliang, Li Jie, Lu Karen H, Hennessy Bryan T, Li Xuesong, Spitz Margaret R, Wei Qingyi, Mills Gordon |
| Frameshift mutations in mammalian target of rapamycin pathway genes and their regional heterogeneity in sporadic colorectal cancers. Human pathology 2015 May 46 (5): 753-60. Choi Mi Ryoung, Yoo Nam Jin, An Chang Hyeok, Lee Sug Hyu |
| Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing. Journal of clinical pathology 2015 Mar 68 (3): 212-7. Manson-Bahr David, Ball Richard, Gundem Gunes, Sethia Krishna, Mills Robert, Rochester Mark, Goody Victoria, Anderson Elizabeth, O'Meara Sarah, Flather Marcus, Keeling Matthew, Yazbek-Hanna Marcelino, Hurst Rachel, Curley Helen, Clark Jeremy, Brewer Daniel S, McDermott Ultan, Cooper Col |
| Study on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric cancer. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 22 (6): 1488-1493. Qi Lei, Sun Kewen, Zhuang Yun, Yang Jing, Chen Jianpi |
| Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer. Molecular genetics & genomic medicine 2019 10 7 (12): e1015. Zhu Junwei, Wu Kaile, Lin Zhangying, Bai Suwen, Wu Jing, Li Peikun, Xue Haowei, Du Juan, Shen Bing, Wang Huiyin, Liu Yeh |
| Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study. Cancers 2020 10 12 (10): . Pagano Maria, Ceresoli Luca Giovanni, Zucali Paolo Andrea, Pasello Giulia, Garassino Marina, Grosso Federica, Tiseo Marcello, Soto Parra Hector, Zanelli Francesca, Cappuzzo Federico, Grossi Francesco, De Marinis Filippo, Pedrazzoli Paolo, Gnoni Roberta, Bonelli Candida, Torricelli Federica, Ciarrocchi Alessia, Normanno Nicola, Pinto Carmi |
| Clinicogenomic characterization of prostate cancer liver metastases. Prostate cancer and prostatic diseases 2022 1 25 (2): 366-369. Alshalalfa Mohammed, Seldon Crystal, Franco Idalid, Vince Randy, Carmona Ruben, Punnen Sanoj, Kaochar Salma, Dess Robert, Kishan Amar, Spratt Daniel E, Sharma Janaki, Dal Pra Alan, Pollack Alan, Abramowitz Matthew C, Mahal Brandon |
| AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20). The oncologist 2023 4 . Suh Koung Jin, Ryu Min-Hee, Zang Dae Young, Bae Woo Kyun, Lee Hye Seung, Oh Hyeon Jeong, Kang Minsu, Kim Ji-Won, Kim Bum Jun, Mortimer Peter G S, Kim Hee Jung, Lee Keun-Wo |
| PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. The Prostate 2024 7 . Philip Sutera, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Phuoc T Tran, Matthew P De |
- Page last reviewed:Feb 1, 2024
- Content source: